Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Martin Dieck
AddedMar 31, 2024
UpdatedMay 31, 2026
Martin Dieck

Martin Dieck

Founder, NeuroTechnology Investors

CrunchbaseLinkedIn

Martin Dieck's Career

NeuroTechnology Investors
NeuroTechnology Investors

Palo Alto, CA, US

Founder
Cerebrotech Medical Systems
Cerebrotech Medical Systems

Pleasanton, CA, US

Board Member· Board
Synchron
Synchron

Newington, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Martin Dieck's Career

NeuroTechnology Investors
NeuroTechnology Investors
Pre-Seed$2.8M52016Palo Alto, CA, US
Founder

Similar to NeuroTechnology Investors

Enavate SciencesEnavate SciencesNew York City, NY, USTechnology, Therapeuticsest. 2022Enavate SciencesNew York City, NY, US · est. 2022

Enavate Sciences: Investing in and fostering growth of innovative therapeutic tech firms.

Private Equity · $300M7
MedTech Venture PartnersMedTech Venture PartnersMenlo Park, CA, USMedical Devicesest. 2015MedTech Venture PartnersMenlo Park, CA, US · est. 2015

MTVP: A VC firm specializing in seed and early-stage investments in medical device companies.

7
Cerebrotech Medical Systems
Cerebrotech Medical Systems
Series A$7.7M322010Pleasanton, CA, US
Board Member· Board

Leadership at Cerebrotech Medical Systems

Joe Cook JrJoe Cook JrBoard Member
Mitch LevinsonMitch LevinsonCo-Founder
Boris RubinskyBoris RubinskyCo-Founder
Carl O'ConnellCarl O'ConnellCEO
Brian LadenBrian LadenBoard Member
Issie RabinovitchIssie RabinovitchBoard Member

Similar to Cerebrotech Medical Systems

Cervel NeurotechCervel NeurotechRedwood City, CA, USMedical Devicesest. 2008Cervel NeurotechRedwood City, CA, US · est. 2008

Cervel Neurotech develops non-invasive neuro-modulation devices for treating psychiatric and neurological disorders.

Pre-Seed · $42.5M30
NeuroChaos SolutionsNeuroChaos SolutionsAustin, TX, USMedical Devicesest. 2012NeuroChaos SolutionsAustin, TX, US · est. 2012

NeuroChaos Solutions: Providing advanced med-tech tools for accurate Traumatic Brain Injury diagnosis & management.

Series A · $1.4M8
Epic NeuroEpic NeuroFountain Valley, CA, USMedical Devicesest. 2016Epic NeuroFountain Valley, CA, US · est. 2016

EPIC Neuro: Minimally invasive brain stimulation & EEG recording for stroke recovery.

Seed · $1M2
Synchron
Synchron
Series C$130M302016Newington, CT, US
Board Member· Board

Leadership at Synchron

Thomas OxleyThomas OxleyCo-Founder
Nicholas OpieNicholas OpieCo-Founder
Thomas OxleyThomas OxleyCEO
Rahul SharmaRahul SharmaCo-Founder

Similar to Synchron

NeuralinkNeuralinkFremont, CA, USBrain Computer Interfacesest. 2016NeuralinkFremont, CA, US · est. 2016

Neuralink Corp., a US-based neurotech firm, innovates brain-computer interfaces for human-computer synergy.

Series D · $686.2M300
Precision NeurosciencePrecision NeuroscienceNew York City, NY, USBrain Computer Interfacesest. 2021Precision NeuroscienceNew York City, NY, US · est. 2021

Precision Neuroscience: Pioneering minimally invasive brain-computer interfaces for neurological treatments.

Series B · $53M34

Martin Dieck's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Martin Dieck

Graham MillerGraham MillerBoard Member · Maven Capital PartnersHoward Martin FillitHoward Martin FillitCo-Founder · Sabik MedicalPETER J. GRUAPETER J. GRUABoard Member · Evolent HealthKenneth NovackKenneth NovackBoard Member · Leerink PartnersChristoph BoehmerChristoph BoehmerBoard Member · Moberg ICU SolutionsJim LiangJim LiangBoard Member · Vincere Biosciences